Zelnorm
RSS
Novartis sweeps away 'Zelnorm' from the market shelves
Mar 31 2007, Anupam Agnihotri

After the request from Food and Drug Administration (FDA), drug giant Novartis Pharmaceuticals Corporation of East Hanover, New Jersey has withdrew Zelnorm from the market.

FDA’s this decision came after Novartis, the Swiss pharmaceutical company,...

Related Stories
Most Recent Most Popular Most Commented
(0)
Novartis to buy Nektar's pulmonary unit for $115M
AP, Basel
Pharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for $115 million.
EU, Switzerland, Novartis, Nektar
made popular Oct 21 2008
(0)
Novartis posts 32-percent rise in 3Q net profit
AP, Basel
Drug maker Novartis AG on Monday reported a 32-percent rise in net profit for the third quarter due to strong sales and the positive impact from a weak U.S. dollar.
EU, Switzerland, Earns, Novartis
made popular Oct 20 2008
(0)
Novartis posts 17 percent rise in 2Q net income
AP, Basel
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.Net income rose...
Switzerland, Novartis, Business, Drug
made popular Jul 17 2008
(0)
Novartis closer to $38B Alcon takeover
AP, Basel
Novartis AG said Tuesday it has completed the first stage of its $38 billion takeover of U.S. eye-care company Alcon Inc.The Swiss pharmaceuticals company paid current...
Switzerland, Novartis, Alcon, Business
made popular Jul 8 2008
(0)
FDA stresses birth defect risks with Roche drug
AP, Washington
Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant...
FDA, Warning, Roche, Drug
made popular May 16 2008
(0)
Vaccines pump up Novartis 1Q profits; US sales down
AP, Basel
Pharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter profits Monday on the back of a declining dollar and solid performance in its vaccines and...
Earns, Switzerland, Novartis, Business
made popular Apr 21 2008
(0)
FDA Investigates Transplant Drugs' Risks
AP, Washington
Regulators are exploring whether organ transplant drugs made by Roche and Novartis increase the risk of an often-fatal neurological disease.The Food and Drug...
Roche, FDA, Investigation, Technology
made popular Apr 10 2008
(0)
Novartis Spending $39 Billion for Alcon
AP, Geneva
Switzerland’s Novartis AG said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The deal for Alcon...
Switzerland, Novartis, Alcon, Business
made popular Apr 7 2008
(0)
Novartis Spending $38 Billion for Alcon
AP, Basel
Switzerland’s Novartis AG said Monday it will spend about $38 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The pharmaceutical...
Switzerland, Novartis, Alcon, Business
made popular Apr 7 2008
(0)
Novartis to Cut 2,500 Jobs by 2010
AP, Basel
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday.The company said it would take a restructuring charge...
Europe, NorthAmerica, Switzerland, United States
made popular Dec 13 2007
(0)
Correction: FDA Approves Leukemia Drug
AP, Washington
In the headline of an Oct. 29 story about the FDA’s approval of a new leukemia drug, The Associated Press misspelled the name of the company and the disease. The...
Novartis, Leukemia, CORRECTIVE, Scitech
made popular Oct 30 2007
(0)
FDA Approves Drug to Treat Leukemia
AP, Washington
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.Tasigna, known generically as...
Europe, NorthAmerica, Switzerland, United States
made popular Oct 29 2007
(0)
Novartis: EU Approves Alzheimer's Patch
AP, Basel
The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer’s disease.The patch, which was approved...
Europe, NorthAmerica, Switzerland, United States
made popular Sep 24 2007
(0)
Biomedical Leaders Gather at Novartis Biotechnology Leadership Camp in Singapore
Gautam, Dehradun
Biomedical leaders and international experts have come together in Singapore for a seminar for discussing the state of biotechnology and sharing their vision for the...
biotechnology, novartis, Technology
made popular Oct 9 2006
(0)
Cancer Drug Gleevec May Lead To Heart Failure
Naveen, Shimla
Dr Thomas Force, who teaches medicine at Jefferson Medical College of Thomas Jefferson University in Philadelphia, has revealed that the cancer-fighting drug, Gleevec...
Cancer, Heart, Gleevec, Blood
made popular Jul 24 2006
(0)
SSP100, a new drug to cure hypertension in diabetics
Pratyush, New Delhi
A hypertension drug, ‘Rasilez’ or ‘SSP100′ may be helpful to treat hypertension in diabetes patients. The drug manufacturer, Novartis, has...
Rasilez, SSP100, Diabetes, Novartis
made popular Jun 15 2006
(0)
Tasigna, a new drug for leukemia by novartis
Pratyush, New Delhi
Tasigna, a new drug for leukemia, made by Novartis AG is a new hope for the patients with uncaring form of leukemia. The new drug has helped more than ninety per cent...
Tasigna, Novartis, Leukemia, New England Journal of Medicine
made popular Jun 15 2006
(0)
FDA to Review Novartis' Oral Diabetes Therapy
Irani, New Delhi
The U.S. Food and Drug Administration had accepted the oral therapy Galvus of Novartis for people with Type 2 diabetes for standard review, the Swiss drug firm said on...
FDA, Novartis, Oral Diabetes Therapy, U.S. Food and Drug Administratio
made popular Mar 31 2006
All Stories
Most Recent Most Popular Most Commented
Related Tags
FDA Food and Drug Administration Health & Fitness Novartis Novartis Pharmaceuticals Corporation
FAQ / Help
Move to top